Notes - Segment Information, Etc.

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7344643

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
6,120,000,000 JPY
929,000,000 JPY
5,185,000,000 JPY
5,000,000 JPY
JPY
6,120,000,000 JPY
1,408,000,000 JPY
7,000,000 JPY
JPY
3,624,000,000 JPY
5,040,000,000 JPY
5,040,000,000 JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
704,000,000 JPY
44,000,000 JPY
525,000,000 JPY
JPY
135,000,000 JPY
569,000,000 JPY
60,000,000 JPY
JPY
128,000,000 JPY
549,000,000 JPY
609,000,000 JPY
737,000,000 JPY
Increase in property, plant and equipment and intangible assets
258,000,000 JPY
89,000,000 JPY
101,000,000 JPY
JPY
68,000,000 JPY
190,000,000 JPY
5,000,000 JPY
JPY
20,000,000 JPY
17,000,000 JPY
22,000,000 JPY
43,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.